Cyclodextrins Papers 2021. May. 26.

A phase 1/2 open label nonrandomized clinical trial of intravenous 2-hydroxypropyl-β-cyclodextrin for acute liver disease in infants with Niemann-Pick C1

Mol Genet Metab Rep

Margaret Reynolds 1, Laura A Linneman 1, Sofia Luna 1, Barbara B Warner 1, Yumirle P Turmelle 1, Sakil S Kulkarni 1, Xuntian Jiang 1, Geetika Khanna 1, Marwan Shinawi 1, Forbes D Porter 2, Daniel S Ory 1, F Sessions Cole 1, Patricia I Dickson 1

DOI: 10.1016/j.ymgmr.2021.100772

Powered by Feebly


メールアドレスが公開されることはありません。 * が付いている欄は必須項目です